1)藤原理太郎・三田村佳典・田川 博・他:アデノウイルス4型結膜炎の院内感染.日眼会誌107:388-392,2003
2)上野智弘・川村朋子・佐伯有祐・他:結膜滲出液を含む涙液を用いたアデノウイルス検出増感キットの評価.臨眼72:481-486,2018
3)Uemura T, Migita H, Ueno T et al:Clinical and virological analysis of epidemic keratoconjunctivitis caused by adenovirus type 54 in a regional ophthalmic clinic in Kyushu, Japan. Clin Ophthalmol 12:511-517, 2018
4)Ohashi Y, Ebihara N, Fujishima H et al:A randomized, placebo-controlled clinical trial of tacrolimus ophthalmic suspension 0.1% in severe allergic conjunctivitis. J Ocul Pharmacol Ther 26:165-173, 2010
5)Huang J, Kadonosono K, Uchio E et al:Antiadenoviral effects of ganciclovir in types inducing keratoconjunctivitis by quantitative polymerase chain reaction methods. Clin Ophthalmol 8:315-320, 2014
6)野田恵理子・山口昌彦・白石 敦・他:流行性角結膜炎を契機に発症したと考えられるドライアイの3症例.あたらしい眼科26:1671-1677,2009
7)Prado SB, Ayora ACR, Fernández CL et al:Topical tacrolimus for corneal subepithelial infiltrates secondary to adenoviral keratoconjunctivitis. Cornea 36:1102-1105, 2017
8)Chigbu DI, Labib BA:Pathogenesis and management of adenoviral keratoconjunctivitis. Infect Drug Resist 11:981-993, 2018